BIOMAT Database Logo BIOMAT Database Logo

Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. 1998

D Vercammen, and R Beyaert, and G Denecker, and V Goossens, and G Van Loo, and W Declercq, and J Grooten, and W Fiers, and P Vandenabeele
Laboratory of Molecular Biology, Flanders Interuniversity Institute for Biotechnology and University of Ghent, B-9000 Ghent, Belgium.

Murine L929 fibrosarcoma cells treated with tumor necrosis factor (TNF) rapidly die in a necrotic way, due to excessive formation of reactive oxygen intermediates. We investigated the role of caspases in the necrotic cell death pathway. When the cytokine response modifier A (CrmA), a serpin-like caspase inhibitor of viral origin, was stably overexpressed in L929 cells, the latter became 1,000-fold more sensitive to TNF-mediated cell death. In addition, TNF sensitization was also observed when the cells were pretreated with Ac-YVAD-cmk or zDEVD-fmk, which inhibits caspase-1- and caspase-3-like proteases, respectively. zVAD-fmk and zD-fmk, two broad-spectrum inhibitors of caspases, also rendered the cells more sensitive, since the half-maximal dose for TNF-mediated necrosis decreased by a factor of 1,000. The presence of zVAD-fmk also resulted in a more rapid increase of TNF-mediated production of oxygen radicals. zVAD-fmk-dependent sensitization of TNF cytotoxicity could be completely inhibited by the oxygen radical scavenger butylated hydroxyanisole. These results indicate an involvement of caspases in protection against TNF-induced formation of oxygen radicals and necrosis.

UI MeSH Term Description Entries
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D002083 Butylated Hydroxyanisole Mixture of 2- and 3-tert-butyl-4-methoxyphenols that is used as an antioxidant in foods, cosmetics, and pharmaceuticals. Butylhydroxyanisole,(1,1-Dimethylethyl)-4-methoxyphenol,AMIF-72,BHA,Butyl Methoxyphenol,Embanox,Nipantiox 1-F,Tenox BHA,AMIF 72,AMIF72,Hydroxyanisole, Butylated,Methoxyphenol, Butyl,Nipantiox 1 F,Nipantiox 1F
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D000590 Amino Acid Chloromethyl Ketones Inhibitors of SERINE ENDOPEPTIDASES and sulfhydryl group-containing enzymes. They act as alkylating agents and are known to interfere in the translation process. Peptide Chloromethyl Ketones,Chloromethyl Ketones, Peptide,Ketones, Peptide Chloromethyl
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

D Vercammen, and R Beyaert, and G Denecker, and V Goossens, and G Van Loo, and W Declercq, and J Grooten, and W Fiers, and P Vandenabeele
[Apoptosis of L929 cells induced by tumor necrosis factor].
January 2000, Tsitologiia,
D Vercammen, and R Beyaert, and G Denecker, and V Goossens, and G Van Loo, and W Declercq, and J Grooten, and W Fiers, and P Vandenabeele
Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells.
May 1989, Cancer research,
D Vercammen, and R Beyaert, and G Denecker, and V Goossens, and G Van Loo, and W Declercq, and J Grooten, and W Fiers, and P Vandenabeele
Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2.
March 1992, The Journal of clinical investigation,
D Vercammen, and R Beyaert, and G Denecker, and V Goossens, and G Van Loo, and W Declercq, and J Grooten, and W Fiers, and P Vandenabeele
Tumor necrosis factor-alpha increases ATP content in metabolically inhibited L929 cells preceding cell death.
November 1997, The Journal of biological chemistry,
D Vercammen, and R Beyaert, and G Denecker, and V Goossens, and G Van Loo, and W Declercq, and J Grooten, and W Fiers, and P Vandenabeele
Pentoxifylline inhibits tumor necrosis factor-alpha-mediated cytotoxicity and cytostasis in L929 murine fibrosarcoma cells.
September 1994, International journal of immunopharmacology,
D Vercammen, and R Beyaert, and G Denecker, and V Goossens, and G Van Loo, and W Declercq, and J Grooten, and W Fiers, and P Vandenabeele
N-acetyl-L-cysteine protects endothelial cells but not L929 tumor cells from tumor necrosis factor-alpha-mediated cytotoxicity.
June 1993, Naunyn-Schmiedeberg's archives of pharmacology,
D Vercammen, and R Beyaert, and G Denecker, and V Goossens, and G Van Loo, and W Declercq, and J Grooten, and W Fiers, and P Vandenabeele
Growth inhibition and cytotoxicity of tumor necrosis factor in L929 cells is enhanced by high cell density and inhibition of mRNA synthesis.
October 1986, Journal of immunology (Baltimore, Md. : 1950),
D Vercammen, and R Beyaert, and G Denecker, and V Goossens, and G Van Loo, and W Declercq, and J Grooten, and W Fiers, and P Vandenabeele
DNA fragmentation and cytotoxicity by recombinant human tumor necrosis factor in L929 fibroblast cells.
April 1992, The Journal of veterinary medical science,
D Vercammen, and R Beyaert, and G Denecker, and V Goossens, and G Van Loo, and W Declercq, and J Grooten, and W Fiers, and P Vandenabeele
Docosahexaenoic acid enrichment can reduce L929 cell necrosis induced by tumor necrosis factor.
April 2006, Biochimica et biophysica acta,
D Vercammen, and R Beyaert, and G Denecker, and V Goossens, and G Van Loo, and W Declercq, and J Grooten, and W Fiers, and P Vandenabeele
Platelet-activating factor antagonists (BN 52021 and BN 50730) inhibit tumor necrosis factor-alfa-mediated cytotoxicity on murine L929 tumor cells.
April 1993, Molecular immunology,
Copied contents to your clipboard!